Abstract-We aimed at studying the role of androgens in the development of cardiovascular pathology in hypertensive female rats. Female TGR(mREN2)27 rats harboring the mouse Ren-2 renin gene were treated with Flutamide (specific antagonist of the androgen receptor, 30 mg/kg per day) starting at 4 weeks of age. Flutamide treatment significantly attenuated the development of hypertension in female rats (systolic blood pressure: treated, 134.5Ϯ5.4 versus control, 165.4Ϯ3.8 mm Hg). Heart hypertrophy was significantly reduced by the treatment (treated, 0.37Ϯ0.008 versus control, 0.45Ϯ0.01 g/100 g body wt). Urinary albumin excretion was blunted (treated, 0.4Ϯ0.1 versus control, 23.1Ϯ7.5 mg/24 hours), collagen III mRNA was significantly decreased, and no histological characteristics of end-organ damage were observed in the kidney after treatment. Flutamide treatment significantly reduced plasma renin concentrations and rat renin mRNA in kidney but not plasma angiotensinogen levels. Plasma levels of estrogens, testosterone, and luteinizing hormone were not altered. These results demonstrate that the androgen receptor antagonist Flutamide protects against hypertension and end-organ damage not only in male but also in female TGR (mREN2) Gender differences have been observed in various hypertensive animal models, with male rats having higher blood pressure than female rats, 2-6 including the transgenic rat TGR(mREN2)27 with an overactive renin-angiotensin system (RAS). 7,8 Evidence is accumulating that androgens may play an important role in gender-associated differences in cardiovascular pathology. We have previously demonstrated that androgens contribute not only to the development of malignant hypertension but also to the associated end-organ damage in transgenic male TGR(mREN2)27 rats with overactive RAS. 9 Females produce androgens as well, which act on specific receptors. 10 Women with hyperandrogenism are considered to be at increased risk for cardiovascular disease. 11-15 Based on a prospective literature survey, it has been recently hypothesized that relative androgen excess is a key factor explaining the increased risk of cardiovascular disease in interpausal women. 16 In the present study, we hypothesized that endogenous androgens may participate in the development of hypertension and end-organ damage in female TGR(mREN2)27 rats. Androgen blockade was achieved by treatment with the antagonist Flutamide, and blood pressure (BP) as well as end-organ damage, RAS, and sex hormones were evaluated.
Methods
Rat StrainsFemale transgenic heterozygous rats [TGR(mREN2)27] (nϭ24 rats) were obtained from the animal facilities of the Max-Delbrück-Center for Molecular Medicine, Berlin, Germany. The rats were housed individually, synchronized to a 12-hour light-dark cycle, at ambient temperature 23Ϯ2°C. A standard rat diet (ssniff R-ZUCHT) and tap water were supplied at libitum.
Study DesignAll experimental protocols were performed in accordance with the guidelines for the use of laboratory animals by the Max-Delbrück-Center for...